What is Certican 0.1 mg, dispergierbare tablets used for?

( ARTG ) Certican is indicated for the prophylaxis of organ rejection in adult patients at mild to moderate immunological risk receiving an allogeneic renal or cardiac transplant and in adult patients receiving an allogeneic hepatic transplant (see Precautions).

What are the side effects of Certican 0.1 mg, dispergierbare tablets?

You can help ensure medicines are safe by reporting the side effects you experience. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Can Certican 0.1 mg, dispergierbare tablets be used during pregnancy?

( AHT ) For the active ingredient everolimus You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What ATC class does Certican 0.1 mg, dispergierbare tablets belong to?

Certican 0.1 mg, dispergierbare tablets: ATC L04AA18. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

OTC

Certican 0.1 mg, dispergierbare tablets

Data updated: 2026-04-11

Available in:

🇩🇪🇬🇧🇹🇷

Form

—

Dosage

—

Route

—

Storage

—

About This Product

Manufacturer

Novartis Pharma Schweiz AG (CH)

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.